View in EDS PDF Full Text

Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
Authors: Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Browne AL; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Ibrahim MFK; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Fanning KP; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Roche S; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Conlon NT; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., O'Neill F; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Meiller J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Cremona M; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland., Morgan C; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland., Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland., Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Whitehall, Glasnevin, Dublin 9, Ireland., Solca F; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland., Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Jan 28; Vol. 12, pp. 1758835919897546. Date of Electronic Publication: 2020 Jan 28 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32064003
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Canonici+A%22">Canonici A</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Browne+AL%22">Browne AL</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Ibrahim+MFK%22">Ibrahim MFK</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Fanning+KP%22">Fanning KP</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Roche+S%22">Roche S</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Conlon+NT%22">Conlon NT</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22O'Neill+F%22">O'Neill F</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Meiller+J%22">Meiller J</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Cremona+M%22">Cremona M</searchLink>; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Morgan+C%22">Morgan C</searchLink>; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Hennessy+BT%22">Hennessy BT</searchLink>; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Eustace+AJ%22">Eustace AJ</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Whitehall, Glasnevin, Dublin 9, Ireland.<br /><searchLink fieldCode="AU" term="%22Solca+F%22">Solca F</searchLink>; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22O'Donovan+N%22">O'Donovan N</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Crown+J%22">Crown J</searchLink>; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2020 Jan 28; Vol. 12, pp. 1758835919897546. <i>Date of Electronic Publication: </i>2020 Jan 28 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32064003
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1758835919897546
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1758835919897546
    Titles:
      – TitleFull: Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Canonici A
      – PersonEntity:
          Name:
            NameFull: Browne AL
      – PersonEntity:
          Name:
            NameFull: Ibrahim MFK
      – PersonEntity:
          Name:
            NameFull: Fanning KP
      – PersonEntity:
          Name:
            NameFull: Roche S
      – PersonEntity:
          Name:
            NameFull: Conlon NT
      – PersonEntity:
          Name:
            NameFull: O'Neill F
      – PersonEntity:
          Name:
            NameFull: Meiller J
      – PersonEntity:
          Name:
            NameFull: Cremona M
      – PersonEntity:
          Name:
            NameFull: Morgan C
      – PersonEntity:
          Name:
            NameFull: Hennessy BT
      – PersonEntity:
          Name:
            NameFull: Eustace AJ
      – PersonEntity:
          Name:
            NameFull: Solca F
      – PersonEntity:
          Name:
            NameFull: O'Donovan N
      – PersonEntity:
          Name:
            NameFull: Crown J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 01
              Text: 2020 Jan 28
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1